Is positron emission tomography using 18F-fluorodeoxyglucose and 11C-acetate valuable in diagnosing indeterminate pancreatic masses?

Scandinavian Journal of Surgery

Volumn 93, Issue 3, 2004, Pages 191-197

  Rasmussen, Ib ^a   Sorensen J ^a   Langstrom B ^a   Haglund, U ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

11C acetate; 18FDG; Adenocarcinoma of the pancreas; Chronic pancreatitis; Focal pancreatitis; Glucose metabolism

Indexed keywords

ACETIC ACID C 11; AMYLASE; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GLUCOSE METABOLISM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS BIOPSY; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; POSITRON EMISSION TOMOGRAPHY;

EID: 8344277437     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690409300304     Document Type: Article

References (26)

1. Carter DC: Cancer of the head of pancreas or chronic pancreatitis? A diagnostic dilemma. Surgery 1992;111:602-603
2. Warburg O: On the origin of cancer cells. Science 1956;123:309-314
3. Gupta N, Bradfield H: Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms. Semin Nucl Med 1996;26:65-73
4. Bares R, Klever P, Hauptmann S, Hellwig D, Fass J, Cremerius U, Schumpelick V, Mittermayer C, Bull U: F18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994;192:79-86
5. Kato T, Fukatsu H, Ito K, Tadokoro M, Ota T, Ikeda M, Isomura T, Ito S, Nishino M, Ishigaki T: Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem. Eur J Nucl Med 1995;22:32-39
6. Inokuma T, Tamaki N, Torizuka T, Fujita T, Magata Y, Yonekura Y, Ohshio G, Imamura M, Konishi J: Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer. J Nucl Med 1995;36:229-235
7. Stollfuss J, Glatting G, Friess H, Kocher F, Berger H, Reske S: 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation [see comments]. Radiology 1995;195:339-344
8. Friess H, Langhans J, Ebert M, Beger HG, Stollfuss J, Reske SN, Buchler MW: Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography [published erratum appears in Gut 1995 Sep; 37:448]. Gut 1995;36:771-777
9. Friess H, Langhans J, Ebert M, Beger HG, Stollfuss J, Reske SN, Buchler MW: Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography [published erratum appears in Gut 1995 Sep; 37:448]. Gut 1995;36:771-777
10. Calderon P, Furnelle J, Christophe J: In vitro lipid metabolism in the rat pancreas I: basal lipid metabolism. Biochem Biophys Acta 1979;574:379-390
11. Shreve PD, Gross MD: Imaging of the pancreas and related diseases with PET carbon-11-acetate. J Nucl Med 1997;38:1305-1310
12. Pike VW, Eakins MN, Allan RM, Selwyn AP: Preparation of [1-11C]acetate - an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot 1982;33:505-512
13. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36
14. Metz CE: ROC methodology in radiological imaging. Invest Radiol 1986;21:720-733
15. Klever P, Bares R, Fass J, Büll V, Schumpelick V: PET with fluorine-18 deoxyglucose for pancreatic disease. Lancet 1992;340:1158-1159
16. Bares R, Klever P, Hellwig D, Hauptmann S, Fass J, Hambuechen U, Zopp L, Mueller B, Buell U, Schumpelick V: Pancreatic cancer detected by positron emission tomography with 18F-labelled deoxyglucose: method and first results. Nucl Med Commun 1993;14:596-601
17. Bares R, Dohmen B, Cremerius U, Fass J, Teusch M, Bull U: [Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma]. Radiologe 1996;36:435-440
18. Zimny M, Bares R, Fass J, Adam G, Cremerius U, Dohmen B, Klever P, Sabri O, Schumpelick V, Buell U: Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med 1997;24:678-682
19. Inokuma T, Tamaki N, Torizuka T, Magata Y, Fujii M, Yonekura Y, Kajiyama T, Ohshio G, Imamura M, Konishi J: Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US. Radiology 1995;195:345-352
20. Rose D, Delbeke D, Beauchamp R, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD: 18Fluorodeoxyglucose- positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg 1999;229:729-737
21. Sendler A, Avril N, Helmberger H, Stollfuss J, Weber W, Bengel F, Schwaiger M, Roder JD, Siewert JR: Preoperative evaluation of pancreatic masses with positron emission tomography using (18)F-fluorodeoxyglucose: diagnostic limitations. World J Surg 2000;24:1121-1129
22. Wahl RL, Henry CA, Ethier SP: Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-glucose in rodents with mammary carcinoma. Radiology 1992;183:643-647
23. Keogan MT, Tyler D, Clark L, Branch MS, McDermott VG, DeLong DM, Coleman RE: Diagnosis of pancreatic carcinoma: role of FDG PET. AJR Am J Roentgenol 1998;171:1565-1570
24. Ho CL, Dehdashti F, Griffeth LK, Buse PE, Balfe DM, Siegel BA: FDG-PET evaluation of indeterminate pancreatic masses. J Comput Assist Tomogr 1996;20:363-369
25. Rajput A, Stellato TA, Faulhaber PF, Vesselle HJ, Miraldi F: The role of fluorodeoxyglucose and positron emission tomography in the evaluation of pancreatic disease. Surgery 1998;124:793-797
26. Imdahl A, Nitzsche E, Krautmann F, Hogerle S, Boos S, Einert A, Sontheimer J, Farthman E: Evaluation of positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg 1999;86:194-199